Starbucks Corp.: “I think that Starbucks got hit by a downgrade last week by Goldman [Sachs] and it was very chilling, and yet I think that [CEO] Kevin Johnson pretty much acquitted himself well. I think there’s probably $2 down and maybe $5 up [in terms of risk-reward]. Look, the stock was at $52, $53, so it’s hard to just come out with guns blazing and say, ‘Buy it here,’ but that’s my take.”

Dynavax Technologies Corp.: “Very controversial in terms of infectious disease. I’d love to have them on. I think the stock’s too low to sell, but I don’t have a catalyst.”

ArcelorMittal SA: “The only steel company I’m recommending is Nucor, NUE. I’m steadfast about that. I think, if you want to own a steel company, you own Nucor. [CEO] John Ferriola – good job there.”

Aimmune Therapeutics Inc.: “I think the stock’s too low. It’s part of the bear market in biotech, and yet I believe that their peanut allergy [medication] is going to be very, very big and a lot more people are impacted by that than people realize.”

Square Inc.: “Absolutely[, I still recommend Square as a long-term hold]. Square is not a value stock. Square is a growth stock. Yes, we will all miss [former CFO] Sarah Friar. She went to Nextdoor, where she’s doing a fantastic job, and she’s just monster good. But I think Square’s franchise is a terrific fintech franchise and I think they’ll do just fine and I think the customers really like Square and, full disclosure, [at my Mexican restaurant] Bar San Miguel, we use it. We use Caviar. We like it. What can I say?”

Alibaba Group Holding Ltd.: “I am not a recommender of any Chinese stocks. That said, if you had to own one, it would be Alibaba, which is an amazing company. I worry about the trade talks. A breakdown will cause a breakdown in Alibaba’s stock.”

Clearway Energy Inc.: “It’s been terrible. It’s been terrible for this kind of flotsam-and-jetsam solar and infrastructure play. That yields 9 percent. To me, when I see a yield like that, that is strictly a red flag, a challenge flag, and I’m going to have to challenge that one. I do not know if that company is doing as well … as once thought.”

PetIQ Inc.: “We’ve got to take advantage of the fact that Idexx Labs, which was at $256, is now down to $189. I like that a lot more.”

Disclosure: Cramer’s charitable trust owns shares of Goldman Sachs.

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money TwitterJim Cramer TwitterFacebookInstagram

Questions, comments, suggestions for the “Mad Money” website?

Originally published at CNBC

Do NOT follow this link or you will be banned from the site!
error: Content is protected !!